首页>
外国专利>
USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF DRY EYE SYNDROME.
USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF DRY EYE SYNDROME.
展开▼
机译:使用JNK信号转导通路的细胞渗透性肽抑制剂治疗干眼综合征。
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention refers to the use of protein kinase inhibitors and more specifically to the use of inhibitors of the protein kinase c-Jun amino terminal kinase, JNK inhibitor (poly-)peptides, chimeric peptides, or of nucleic acids encoding same as well as pharmaceutical compositions containing same, for the treatment of dry eye syndrome.
展开▼